introduction on physiological pharmacokinetics, Chemical Engineering

Question : Give a basic introduction on PHYSIOLOGICAL PHARMACOKINETICS?

Answer: The history and bases of physiological pharmacokinetics will be briefly reviewed, pointing out some misconceptions, e.g. that membrane transport cannot be incorporated into these models and only the flow-limited case can be handled. Several recent literature reviews will be given for those wanting further details on the modeling and/or specific drugs. This will be followed by a brief description of a few examples, and the paper will conclude with my views of the most useful future research in the area.

The basic idea of physiological pharmacokinetics was to extend pharmacokinetic modeling so that quantitative aspects of other biological areas can be incorporated. For example, this includes what is known about physiological differences and similarities between species, membrane biophysics, biochemical kinetics, and others to be illustrated later. The approach will be to focus the models on anatomically real local tissue regions, including their blood flow, binding and transport characteristics. Certain aspects are similar to the compartmental modeling methods of mathematical biology, see, e.g. Riggs (1970) or Resigno and Segre (1966)---or of what will be termed "classical pharmacokinetics' which is primarily concerned with the prediction of blood levels for various dosage regimens--see Gibaldi and Perrier (1982) for a comprehensive treatment.

Often, however, these compartments have been rather abstract mathematical constructs, whose number and properties were only able to be ascertained by curve-fitting of experimental blood sample data. Useful insights into the quantitative operation of the body were obtained, although specific organ levels were usually not considered. However, physiological pharmacokinetics attempts to also predict the various organ and tissue levels, even extra- vs intra-cellular concentrations.

This concept of utilization of known anatomical and physiological functions as a basis for pharmacokinetic models was earlier proposed by Teorell (1937). This remarkable work was not able to be fully utilized, however, because of the lack of reasonable computing capabilities. When the latter became feasible, the number of differential equations that needed to be solved in comprehensive models was not of crucial importance, and multicompartment models based on known physiology were formulated by Bischoff and Brown (1966). The basis was to use a compartment as an actual local tissue region, as proposed by Bellman et al. (1960).

There are several specific reasons for pursuing this approach. One is the scientific intellectual satisfaction of having quantitative predictive models based on underlying knowledge, rather than the more empirical, curvefitting approaches often used. The latter are always needed to some extent, of course, but should hopefully be minimized. Another important purpose is to aid in the constant problems of interpreting animal experiments in drug screening, dosage regimen formulation, and similar matters. In quantitative terms this can be called 'scaling' the results from one species to another, and ultimately to man, as described by Dedrick (1973).

Both of these results should ultimately result in more efficient experimentation, since the aspects that can be predicted a priori can be done by model, allowing the investigator to focus more specifically on the truly unknown areas. A feature that has both research and practical importance is that the model results are mostly concerned with organ concentrations of drug; this appears to be of increasing interest both for clinical application and also will provide a much clearer basis for studying pharmacodynamics (drug effects) for agents with known sites of action.

The philosophical basis of the present approach resides in chemical engineering modeling and design, where several of the problems of combined flow, diffusion, and chemical reactions are similar to the present problem--see Himmelblau and Bischoff (1968).

Posted Date: 2/15/2013 3:19:43 AM | Location : United States







Related Discussions:- introduction on physiological pharmacokinetics, Assignment Help, Ask Question on introduction on physiological pharmacokinetics, Get Answer, Expert's Help, introduction on physiological pharmacokinetics Discussions

Write discussion on introduction on physiological pharmacokinetics
Your posts are moderated
Related Questions
advantages of fuel cell over batteries

What is wrong with each of the following attempts to write an electron configuration? Justify your answer with suitable explanation. (a) 1s22s3 (b) 1s22s22p23s2 (c) 1s22s23s2 (d) 1

Requisites of refractory material or essential requirements of good refractory: a.      It should be able to withstand high temperature. The appropriate refractory is chose

Objectives : After doing this exercise based on two different labs of Zoology/Botany/Chemistry Physics, you should be able to: 1. State the check in and check out procedure of

Explain covalent bond A covalent bond is a form of chemical bonding that is characterized by the sharing of pairs of electrons among atoms, or among atoms and other covalent

Consider the following non-linear ordinary equation with an initial condition, y(t=0)=2. ?? ′ =4?? 0.8?? -0.5?? Compute and plot the solution as a function of time from 0 to

Give the properties and applications of Bakelite. This is most common type of phenol formaldehyde. This is hard, thermosetting, dark coloured material. Its major properties

how do you write a lab report about conductometric titrations

why only size influence the movement of protein in sds page

Why some overhanging beams have point of contra flexure?